Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


5 Osteoporos Int
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Osteoporos Int

  1. ZHANG J, Zhang T, Xu X, Cai Q, et al
    Zoledronic acid combined with percutaneous kyphoplasty in the treatment of osteoporotic compression fracture in a single T12 or L1 vertebral body in postmenopausal women.
    Osteoporos Int. 2019 Apr 11. pii: 10.1007/s00198-019-04896.
    PubMed     Text format     Abstract available

  2. REGINSTER J-, Bianic F, Campbell R, Martin M, et al
    Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis.
    Osteoporos Int. 2019 Apr 6. pii: 10.1007/s00198-019-04947.
    PubMed     Text format     Abstract available

  3. ZHU W, Xu C, Zhang JG, He H, et al
    Gene-based GWAS analysis for consecutive studies of GEFOS.
    Osteoporos Int. 2018;29:2645-2658.
    PubMed     Text format     Abstract available

  4. KENDLER DL, Body JJ, Brandi ML, Broady R, et al
    Bone management in hematologic stem cell transplant recipients.
    Osteoporos Int. 2018;29:2597-2610.
    PubMed     Text format     Abstract available

  5. IRELAND A, Crozier SR, Heazell AEP, Ward KA, et al
    Breech presentation is associated with lower bone mass and area: findings from the Southampton Women's Survey.
    Osteoporos Int. 2018;29:2275-2281.
    PubMed     Text format     Abstract available

    PLoS One

  6. CHEN YY, Fang WH, Wang CC, Kao TW, et al
    Body fat has stronger associations with bone mass density than body mass index in metabolically healthy obesity.
    PLoS One. 2018;13:e0206812.
    PubMed     Text format     Abstract available

  7. CHAI SC, Foley EM, Arjmandi BH
    Anti-atherogenic properties of vitamin E, aspirin, and their combination.
    PLoS One. 2018;13:e0206315.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.